Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion

AIM:To evaluate the long-term efficacy and safety of retinal photocoagulation combined with intravitreal injection of Ranibizumab(IVR)and simple Ranibizumab in the treatment of branch retinal vein occlusion secondary macular edema(BRVO-ME).METHODS: The literatures related to randomized controlled cl...

Full description

Bibliographic Details
Main Authors: Xiang-Rui Wu, Feng-Ming Liang, Shuai Song
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2021-01-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2021/1/202101019.pdf
_version_ 1818342922457710592
author Xiang-Rui Wu
Feng-Ming Liang
Shuai Song
author_facet Xiang-Rui Wu
Feng-Ming Liang
Shuai Song
author_sort Xiang-Rui Wu
collection DOAJ
description AIM:To evaluate the long-term efficacy and safety of retinal photocoagulation combined with intravitreal injection of Ranibizumab(IVR)and simple Ranibizumab in the treatment of branch retinal vein occlusion secondary macular edema(BRVO-ME).METHODS: The literatures related to randomized controlled clinical studies on the treatment of BRVO-ME with laser and Ranibizumab in Embase, The Cochrane Library, PubMed, China National Knowledge Infrastructure(CNKI), Wanfang Database and China Science and Technology Journal Database(VIP)were systematically retrieved, and the risk assessment was carried out and data indicators were extracted for the included studies. RevMan 5.3 software was used for data analysis and funnel plot was used to evaluate publication bias.RESULTS: Totally 7 studies were included, with 641 eyes. There was no significant difference in the best corrected visual acuity(BCVA)between the laser combined with Ranibizumab group and the simple Ranibizumab group at 12mo \ and 24mo \ after treatment. There was no significant difference in central foveal thickness between the two groups at 12mo \ and 24mo \. There were no statistically significant differences in the injection times of Ranibizumab and the incidence of final adverse events between the two groups at 12mo and 24mo after treatment.CONCLUSION: Compared with the treatment of BRVO-ME with simple Ranibizumab, there was no significant difference in the long-term efficacy of vision and central foveal thickness for the laser combined with Ranibizumab, and there was no significant difference in the injection times and safety of Ranibizumab.
first_indexed 2024-12-13T16:22:23Z
format Article
id doaj.art-889a9704b118444f81e381f7c7b8f269
institution Directory Open Access Journal
issn 1672-5123
language English
last_indexed 2024-12-13T16:22:23Z
publishDate 2021-01-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-889a9704b118444f81e381f7c7b8f2692022-12-21T23:38:41ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232021-01-01211929810.3980/j.issn.1672-5123.2021.1.19202101019Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusionXiang-Rui Wu0Feng-Ming Liang1Shuai Song2First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, ChinaFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, ChinaFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, ChinaAIM:To evaluate the long-term efficacy and safety of retinal photocoagulation combined with intravitreal injection of Ranibizumab(IVR)and simple Ranibizumab in the treatment of branch retinal vein occlusion secondary macular edema(BRVO-ME).METHODS: The literatures related to randomized controlled clinical studies on the treatment of BRVO-ME with laser and Ranibizumab in Embase, The Cochrane Library, PubMed, China National Knowledge Infrastructure(CNKI), Wanfang Database and China Science and Technology Journal Database(VIP)were systematically retrieved, and the risk assessment was carried out and data indicators were extracted for the included studies. RevMan 5.3 software was used for data analysis and funnel plot was used to evaluate publication bias.RESULTS: Totally 7 studies were included, with 641 eyes. There was no significant difference in the best corrected visual acuity(BCVA)between the laser combined with Ranibizumab group and the simple Ranibizumab group at 12mo \ and 24mo \ after treatment. There was no significant difference in central foveal thickness between the two groups at 12mo \ and 24mo \. There were no statistically significant differences in the injection times of Ranibizumab and the incidence of final adverse events between the two groups at 12mo and 24mo after treatment.CONCLUSION: Compared with the treatment of BRVO-ME with simple Ranibizumab, there was no significant difference in the long-term efficacy of vision and central foveal thickness for the laser combined with Ranibizumab, and there was no significant difference in the injection times and safety of Ranibizumab.http://ies.ijo.cn/cn_publish/2021/1/202101019.pdfretinal laser photocoagulationranibizumabanti-vegf therapymacular edema secondary to branch retinal vein occlusionmeta-analysislong-term efficacysafety
spellingShingle Xiang-Rui Wu
Feng-Ming Liang
Shuai Song
Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
Guoji Yanke Zazhi
retinal laser photocoagulation
ranibizumab
anti-vegf therapy
macular edema secondary to branch retinal vein occlusion
meta-analysis
long-term efficacy
safety
title Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
title_full Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
title_fullStr Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
title_full_unstemmed Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
title_short Meta-analysis of long-term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
title_sort meta analysis of long term efficacy of combined regimen in treatment of macular edema secondary to branch retinal vein occlusion
topic retinal laser photocoagulation
ranibizumab
anti-vegf therapy
macular edema secondary to branch retinal vein occlusion
meta-analysis
long-term efficacy
safety
url http://ies.ijo.cn/cn_publish/2021/1/202101019.pdf
work_keys_str_mv AT xiangruiwu metaanalysisoflongtermefficacyofcombinedregimenintreatmentofmacularedemasecondarytobranchretinalveinocclusion
AT fengmingliang metaanalysisoflongtermefficacyofcombinedregimenintreatmentofmacularedemasecondarytobranchretinalveinocclusion
AT shuaisong metaanalysisoflongtermefficacyofcombinedregimenintreatmentofmacularedemasecondarytobranchretinalveinocclusion